FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
The European STXBP1 Consortium (ESCO) is excited to share groundbreaking news in the quest for new treatments for STXBP1 disorders! […]